Castle Biosciences, Inc. Common Stock — Grafico, Quotazione e Notizie (NASDAQ:CSTL) | MetaTrader

Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche

Trimestrale Annuale

Market Capitalization 725.7385 M
Employee 883
Founded 2007
CEO N/A
Website www.castlebiosciences.com
Headquarter Delaware, United States
FIGI BBG006YWVSR3
Industry Technology

Ricavi totali

Utile netto

Utile base per azione (EPS base)

Debito totale

Liquidità libera

Disponibilità liquide e mezzi equivalenti

725.74 M Capitalizzazione di mercato

Rapporto prezzo/utili

-46.87

Rapporto prezzo/fatturato

3.28

Notizie

Il CEO di Castle Biosciences Maetzold vende azioni per 106.598$

Castle Biosciences: Buying The Remaining DecisionDx-Melanoma Upside (NASDAQ:CSTL)

Castle Biosciences, Inc. (CSTL) Discusses Clinical Utility and Evidence Supporting DecisionDx Melanoma Test and DECIDE Study Transcript

CTMX Stock Rallies on Strong Phase I Colorectal Cancer Study Data

AstraZeneca's Imfinzi Secures Approval for Gastric Cancer in the EU

FDA Approves NVS' Cosentyx in Hidradenitis Suppurativa for Adolescents

United Therapeutics Stock Surges 32% in 6 Months: Here's Why

Beam Therapeutics Stock Surges 23% in 6 Months: What's Driving It?

JNJ Seeks Label Expansion of Multiple Myeloma Drug Tecvayli in the EU

Stokes Frank vende titoli Castle Biosciences (CSTL) per 192.000$

Stokes Frank sells Castle Biosciences (CSTL) stock worth $192k

LLY Wins CHMP Nod for Olumiant's Expanded Use in Alopecia Areata